Picone et al. addressed that metformin activated NF-κB by translocating it from the cytoplasm to the nucleus where NF-κB increased APP and Pres 1 transcription, suggesting metformin promoted the progression of AD [15]. The gene discussed is NFKB1; the disease is Alzheimer disease.